Health product recall

PMS-Galantamine ER (2019-06-25)

Starting date:
June 25, 2019
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-70353

Last updated: 2019-07-05

Summary

  • Product: PMS-Galantamine ER 8mg Capsule

Reason

The dissolution in the affected lot is out of specification.

Depth of distribution

Wholesalers, Retailers, Healthcare Establishments

Affected products

PMS-Galantamine ER 8mg Capsule

DIN, NPN, DIN-HIM

DIN 02398370

Dosage form

Capsule (Extended Release)

Strength

Galantamine 8 mg

Lot or serial number

616515

Companies

Recalling Firm
Pharmascience Inc.
100, 6111 Royalmount Avenue
Montreal
H4P 2T4
Quebec
CANADA
Marketing Authorization Holder
Pharmascience Inc.
100, 6111 Royalmount Avenue
Montreal
H4P 2T4
Quebec
CANADA

Date modified: